Savitri D. Kabade, Y. Venkatesh, S. Karthik, Vikas Kumar
{"title":"格拉司琼与哌啶预防脊髓麻醉围手术期寒战的比较研究","authors":"Savitri D. Kabade, Y. Venkatesh, S. Karthik, Vikas Kumar","doi":"10.4103/2394-6954.190769","DOIUrl":null,"url":null,"abstract":"Aims: Shivering, the \"big little problem,\" has an incidence of 19-33% following spinal anesthesia. Recently, studies showed the involvement of serotonergic system in the control of postanesthetic shivering. Pharmacological management includes opioids (pethidine) and nonopioids like 5-HT3 receptor antagonists (ondansetron and granisetron). Pethidine which is considered as a time-tested drug for control of shivering can have adverse effects such as respiratory depression, nausea, and vomiting. This study was performed to compare the effect of prophylactic granisetron versus pethidine in prevention of perioperative shivering in patients under spinal anesthesia. Settings and Design: A prospective randomized, double blinded study was conducted on 60 patients of ASA I and II physical status aged between 20-50 years scheduled for elective lower abdominal surgeries under spinal anesthesia. Subjects and Methods: After obtaining ethical committee clearance and patient consent, sixty American Statistical Association Grade I and II patients, aged 20-50 years scheduled for elective lower abdominal surgeries under spinal anesthesia were recruited for a randomized double-blinded study divided into Group G and Group P and received intravenous (IV) granisetron 40 mcg/kg and pethidine 0.4 mg/kg, respectively. Perioperatively, vitals and core temperature were monitored and shivering was assessed using 5-item scale once in every 15 min up to 6 h. Statistical Analysis: The results were analysed using Statistical Package for Social Science software. Results: Of the sixty patients we studied, the demographic profile between the two groups was comparable. Six patients had shivering in each group. The mean temperature at which patient developed shivering was 36.31°C in Group G and 35.85°C in Group P. The mean time of onset for shivering to occur in Group G was 95 min and in Group P was 65 min. None of the patients received rescue drug. Patients in both the groups were hemodynamically stable. Conclusions: Prophylactic granisetron 40 μg/kg IV is as effective as pethidine 0.4 mg/kg IV in preventing perioperative shivering following spinal anesthesia and also reduces the need of antiemetics.","PeriodicalId":17751,"journal":{"name":"Karnataka Anaesthesia Journal","volume":"34 1","pages":"14 - 18"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"Comparative study of granisetron versus pethidine for the prevention of perioperative shivering under spinal Anesthesia\",\"authors\":\"Savitri D. Kabade, Y. Venkatesh, S. Karthik, Vikas Kumar\",\"doi\":\"10.4103/2394-6954.190769\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims: Shivering, the \\\"big little problem,\\\" has an incidence of 19-33% following spinal anesthesia. Recently, studies showed the involvement of serotonergic system in the control of postanesthetic shivering. Pharmacological management includes opioids (pethidine) and nonopioids like 5-HT3 receptor antagonists (ondansetron and granisetron). Pethidine which is considered as a time-tested drug for control of shivering can have adverse effects such as respiratory depression, nausea, and vomiting. This study was performed to compare the effect of prophylactic granisetron versus pethidine in prevention of perioperative shivering in patients under spinal anesthesia. Settings and Design: A prospective randomized, double blinded study was conducted on 60 patients of ASA I and II physical status aged between 20-50 years scheduled for elective lower abdominal surgeries under spinal anesthesia. Subjects and Methods: After obtaining ethical committee clearance and patient consent, sixty American Statistical Association Grade I and II patients, aged 20-50 years scheduled for elective lower abdominal surgeries under spinal anesthesia were recruited for a randomized double-blinded study divided into Group G and Group P and received intravenous (IV) granisetron 40 mcg/kg and pethidine 0.4 mg/kg, respectively. Perioperatively, vitals and core temperature were monitored and shivering was assessed using 5-item scale once in every 15 min up to 6 h. Statistical Analysis: The results were analysed using Statistical Package for Social Science software. Results: Of the sixty patients we studied, the demographic profile between the two groups was comparable. Six patients had shivering in each group. The mean temperature at which patient developed shivering was 36.31°C in Group G and 35.85°C in Group P. The mean time of onset for shivering to occur in Group G was 95 min and in Group P was 65 min. None of the patients received rescue drug. Patients in both the groups were hemodynamically stable. Conclusions: Prophylactic granisetron 40 μg/kg IV is as effective as pethidine 0.4 mg/kg IV in preventing perioperative shivering following spinal anesthesia and also reduces the need of antiemetics.\",\"PeriodicalId\":17751,\"journal\":{\"name\":\"Karnataka Anaesthesia Journal\",\"volume\":\"34 1\",\"pages\":\"14 - 18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Karnataka Anaesthesia Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/2394-6954.190769\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Karnataka Anaesthesia Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2394-6954.190769","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10
摘要
目的:脊髓麻醉后发抖的“大问题小问题”发生率为19-33%。近年来的研究表明,血清素能系统参与了麻醉后寒战的控制。药物管理包括阿片类药物(哌啶)和非阿片类药物,如5-HT3受体拮抗剂(昂丹司琼和格拉司琼)。哌替啶被认为是一种久经考验的控制颤抖的药物,但它会产生不良反应,如呼吸抑制、恶心和呕吐。本研究的目的是比较预防性格拉司琼与哌啶预防脊髓麻醉患者围手术期寒战的效果。背景与设计:本研究是一项前瞻性随机双盲研究,研究对象为60例年龄在20-50岁的ASA I和II级身体状况的患者,计划在脊髓麻醉下择期进行下腹部手术。对象和方法:经伦理委员会批准和患者同意,招募60例年龄在20-50岁、计划在脊髓麻醉下择期行下腹手术的美国统计协会一级和二级患者进行随机双盲研究,分为G组和P组,分别静脉注射格拉司琼40 mcg/kg和哌啶0.4 mg/kg。围手术期监测生命体征和核心体温,每15分钟至6小时用5项量表评估一次寒战。统计分析:使用Statistical Package for Social Science软件对结果进行分析。结果:在我们研究的60例患者中,两组之间的人口统计学特征具有可比性。每组有6名患者发抖。G组患者发生寒战的平均温度为36.31℃,P组患者发生寒战的平均时间为35.85℃。G组患者发生寒战的平均时间为95 min, P组患者发生寒战的平均时间为65 min。两组患者血流动力学稳定。结论:预防性格拉司琼40 μg/kg IV与哌啶0.4 mg/kg IV预防脊髓麻醉后围手术期寒战的效果相同,且可减少止吐药的使用。
Comparative study of granisetron versus pethidine for the prevention of perioperative shivering under spinal Anesthesia
Aims: Shivering, the "big little problem," has an incidence of 19-33% following spinal anesthesia. Recently, studies showed the involvement of serotonergic system in the control of postanesthetic shivering. Pharmacological management includes opioids (pethidine) and nonopioids like 5-HT3 receptor antagonists (ondansetron and granisetron). Pethidine which is considered as a time-tested drug for control of shivering can have adverse effects such as respiratory depression, nausea, and vomiting. This study was performed to compare the effect of prophylactic granisetron versus pethidine in prevention of perioperative shivering in patients under spinal anesthesia. Settings and Design: A prospective randomized, double blinded study was conducted on 60 patients of ASA I and II physical status aged between 20-50 years scheduled for elective lower abdominal surgeries under spinal anesthesia. Subjects and Methods: After obtaining ethical committee clearance and patient consent, sixty American Statistical Association Grade I and II patients, aged 20-50 years scheduled for elective lower abdominal surgeries under spinal anesthesia were recruited for a randomized double-blinded study divided into Group G and Group P and received intravenous (IV) granisetron 40 mcg/kg and pethidine 0.4 mg/kg, respectively. Perioperatively, vitals and core temperature were monitored and shivering was assessed using 5-item scale once in every 15 min up to 6 h. Statistical Analysis: The results were analysed using Statistical Package for Social Science software. Results: Of the sixty patients we studied, the demographic profile between the two groups was comparable. Six patients had shivering in each group. The mean temperature at which patient developed shivering was 36.31°C in Group G and 35.85°C in Group P. The mean time of onset for shivering to occur in Group G was 95 min and in Group P was 65 min. None of the patients received rescue drug. Patients in both the groups were hemodynamically stable. Conclusions: Prophylactic granisetron 40 μg/kg IV is as effective as pethidine 0.4 mg/kg IV in preventing perioperative shivering following spinal anesthesia and also reduces the need of antiemetics.